Literature DB >> 21383701

Cancer drugs: remedy required.

.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21383701     DOI： 10.1038/nm0311-231

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  When are "positive" clinical trials in oncology truly positive?

Authors:  Alberto Ocana; Ian F Tannock
Journal:  J Natl Cancer Inst       Date:  2010-12-03       Impact factor: 13.506

2.  Projections of the cost of cancer care in the United States: 2010-2020.

Authors:  Angela B Mariotto; K Robin Yabroff; Yongwu Shao; Eric J Feuer; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2011-01-12       Impact factor: 13.506

Review 3.  Cancer metastasis as a therapeutic target.

Authors:  Jonathan Sleeman; Patricia S Steeg
Journal:  Eur J Cancer       Date:  2010-03-20       Impact factor: 9.162
  3 in total
  4 in total

1.  Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer.

Authors:  Ryuichi Murase; Rumi Kawamura; Eric Singer; Arash Pakdel; Pranamee Sarma; Jonathon Judkins; Eiman Elwakeel; Sonali Dayal; Esther Martinez-Martinez; Mukkanti Amere; Ramesh Gujjar; Anu Mahadevan; Pierre-Yves Desprez; Sean D McAllister
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

Review 2.  Somatic variation and cancer: therapies lost in the mix.

Authors:  Andrew V Biankin; Thomas J Hudson
Journal:  Hum Genet       Date:  2011-06-05       Impact factor: 5.881

3.  Inhibiting delta-6 desaturase activity suppresses tumor growth in mice.

Authors:  Chengwei He; Xiying Qu; Jianbo Wan; Rong Rong; Lili Huang; Chun Cai; Keyuan Zhou; Yan Gu; Steven Y Qian; Jing X Kang
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

4.  A review of the Institute of Medicine's analysis of using chimpanzees in biomedical research.

Authors:  Robert C Jones; Ray Greek
Journal:  Sci Eng Ethics       Date:  2013-04-25       Impact factor: 3.525
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.